Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 350

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 1
Chunk 350
---
9A. Controls and Procedures.

Evaluation
of Disclosure Controls and Procedures

Our
management, our Chief Executive Officer (our principal executive officer) and our Chief Financial Officer (our principal financial officer)
(the “Certifying Officers”), has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules
13a-15(e) or 15d-15(e) under the Exchange Act) as of December 31, 2024. The term “disclosure controls and procedures,”
as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that
are designed to ensure that information required to be disclosed by the company in the reports that it files or submits under the Exchange
Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure
controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed
by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s
management, including its principal executive and principal accounting officers, or persons performing similar functions, as appropriate
to allow timely decisions regarding required disclosure. Our management recognizes that any controls and procedures, no matter how well
designed and operated, can provide only reasonable assurance of achieving their objectives and our management necessarily applies its
judgment in evaluating the cost-benefit relationship of possible controls and procedures. The Certifying Officers have concluded, based
on their evaluation as of the end of the period covered by this Report, that our disclosure controls and procedures were effective
to provide reasonable assurance that the objectives of our disclosure control system were met.

Management’s
Annual Report on Internal Control over Financial Reporting

Management of the
Company is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Section 13a-15(f)
of the Securities Exchange Act of 1934, as amended). Internal control over financial reporting is a process designed by, or under
the supervision of, the Company’s principal financial officer to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of the Company’s financial statements for external reporting purposes in conformity with U.S. generally
accepted accounting principles and include those policies and procedures that (i) pertain to the maintenance of records that in reasonable
detail accurately and fairly reflect the transactions and disposition of the